Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Next generation sequencing predicting clinical effect of immunotherapy on adult rhabdomyosarcoma patient: A case report.

Medicine - 26 May 2023

Sun Xiaogang, Wang Xinyu, Zhou Jun, Xu Yali, Zhang Hao, Xu Mian, Shen Jiaojiao, Shi Xiaoliang, Song Wei, Li Jun

Abstract excerpt

RATIONALE: Rhabdomyosarcoma (RMS) is a rare sarcoma that rarely occurs in adults and accounts for only 1% of all adult tumors. The standard treatment for RMS is surgical resection, radiotherapy, and chemotherapy. PATIENT CONCERNS: Adult patients often present with an aggressive course and poor prognosis. DIAGNOSES: The patient was diagnosed with RMS in September 2019 and was confirmed by hematoxylin-eosin...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Immunotherapy

Share to Microsatellite Instability

Share to Mutation

Share to Rhabdomyosarcoma

Source

Open in PubMed Open full text

Identifiers

PMID: 37233406
DOI: 10.1097/MD.0000000000033858
PMCID: PMC10219687

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Next generation sequencing predicting clinical effect of immunotherapy on adult rhabdomyosarcoma patient: A case report.PMID 37233406Read ↗

Rhabdomyosarcoma: How Advanced Molecular Methods Are Shaping the Diagnostic and Therapeutic Paradigm.Semantic proximity Read ↗

Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular Biomarkers.Semantic proximity Read ↗

Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult Rhabdomyosarcomas.Semantic proximity Read ↗

Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular BiomarkersSemantic proximity Read ↗

Aberrant CDK4 Amplification in Refractory Rhabdomyosarcoma as Identified by Genomic ProfilingSemantic proximity Read ↗

Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma.Semantic proximity Read ↗

[Analysis of the effect of gene mutations on the efficacy of ruxolitinib in patients with myelofibrosis based on second-generation sequencing technology].Semantic proximity Read ↗

MYBPC2 and MYL1 as Significant Gene Markers for RhabdomyosarcomaSemantic proximity Read ↗

MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomasSemantic proximity Read ↗

miR-203, a Tumor Suppressor Frequently Down-regulated by Promoter Hypermethylation in RhabdomyosarcomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.